2024
High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage
Lai Y, Koelmel J, Walker D, Price E, Papazian S, Manz K, Castilla-Fernández D, Bowden J, Nikiforov V, David A, Bessonneau V, Amer B, Seethapathy S, Hu X, Lin E, Jbebli A, McNeil B, Barupal D, Cerasa M, Xie H, Kalia V, Nandakumar R, Singh R, Tian Z, Gao P, Zhao Y, Froment J, Rostkowski P, Dubey S, Coufalíková K, Seličová H, Hecht H, Liu S, Udhani H, Restituito S, Tchou-Wong K, Lu K, Martin J, Warth B, Pollitt K, Klánová J, Fiehn O, Metz T, Pennell K, Jones D, Miller G. High-Resolution Mass Spectrometry for Human Exposomics: Expanding Chemical Space Coverage. Environmental Science And Technology 2024, 58: 12784-12822. PMID: 38984754, PMCID: PMC11271014, DOI: 10.1021/acs.est.4c01156.Peer-Reviewed Original ResearchHigh-resolution mass spectrometryChemical spaceCoverage of chemical spaceMass spectrometryAccurate mass measurementsChemical space coverageNon-target approachHuman exposomeAnalytical workflowMass measurementsDisease outcomeGenetic driversSpectrometryHarmonized workflowMulti-omics integrationRetrospective validationCare providersChemistsMetabolomicsSpace coverageBiomoleculesHypothesis-drivenDisease
2018
Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson’s Disease: Current Progress and Future Perspectives
Gill E, Koelmel J, Yost R, Okun M, Vedam-Mai V, Garrett T. Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson’s Disease: Current Progress and Future Perspectives. Analytical Chemistry 2018, 90: 2979-2986. PMID: 29384654, DOI: 10.1021/acs.analchem.7b04084.Peer-Reviewed Original ResearchConceptsParkinson's diseaseMetabolic signaturesContext of PDDegeneration of motorProdromal Parkinson's diseaseDisease-modifying therapiesBasal ganglia circuitryMotor deficitsDopaminergic neuronsDopamine metabolitesSubstantia nigraDisease progressionDefinitive biomarkersEarly diagnosisUseful biomarkerNeurodegenerative disordersDiseaseNonmotor componentsField of MSBiomarkersPreanalytical factorsMetabolomics studiesCellular pathwaysFuture perspectivesEarly stages
2017
Tissue distribution of perfluoroalkyl acids and health status in wild Mozambique tilapia (Oreochromis mossambicus) from Loskop Dam, Mpumalanga, South Africa
Bangma J, Reiner J, Botha H, Cantu T, Gouws M, Guillette M, Koelmel J, Luus-Powell W, Myburgh J, Rynders O, Sara J, Smit W, Bowden J. Tissue distribution of perfluoroalkyl acids and health status in wild Mozambique tilapia (Oreochromis mossambicus) from Loskop Dam, Mpumalanga, South Africa. Journal Of Environmental Sciences 2017, 61: 59-67. PMID: 29191316, PMCID: PMC6584947, DOI: 10.1016/j.jes.2017.03.041.Peer-Reviewed Original ResearchConceptsHealth statusInflammatory diseasesFish health statusAdipose tissueHealthy tilapiaTissue distributionTissue concentrationsPerfluoroalkyl acidsMale Mozambique tilapiaKidneyPerfluorooctanoic acidTissueBurdenLiverHigher PFAA concentrationsPerfluorooctanesulfonic acidStatusOrgansMozambique tilapiaPFAA concentrationsStatistical analysisSpleenIncidenceDiseaseCare